Massachusetts Eye And Ear Infirmary
- Type
- Teaching hospital
- Where
- Boston, MA
- Medicare CCN
- 220075
- Received
- $1,795,687 in 76 records, 2024 ($1,276,651 general, $519,035 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: Massachusetts Eye and Ear Infirmary Fuzzy (name and state)
- Plan sponsor: MASSACHUSETTS EYE AND EAR INFIRMARY Fuzzy (name and state)
- Federal award recipient: MASSACHUSETTS EYE AND EAR INFIRMARY Fuzzy (name and state)
- Lobbying client: MASSACHUSETTS EYE AND EAR INFIRMARY Fuzzy (name and state)
- Patent assignee: Massachusetts Eye and Ear Infirmary Fuzzy (name and state)
- Trademark owner: Massachusetts Eye and Ear Infirmary Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2024 | General payment | 50 | $1,276,651 |
| 2024 | Research payment | 26 | $519,035 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | 4 | $783,641 | 2024 |
| Regeneron Pharmaceuticals, Inc. | 6 | $288,799 | 2024 |
| Amgen Inc. | 1 | $219,468 | 2024 |
| Janssen Research & Development, LLC | 3 | $118,360 | 2024 |
| KARL STORZ Endoscopy-America | 11 | $97,118 | 2024 |
| Medtronic, Inc. | 1 | $50,000 | 2024 |
| Inspire Medical Systems, Inc. | 5 | $44,952 | 2024 |
| Sumitomo Pharma Co., Ltd. | 1 | $44,947 | 2024 |
| bioMerieux Inc | 1 | $36,045 | 2024 |
| KYOWA KIRIN, INC. | 6 | $24,700 | 2024 |
| Biogen, Inc. | 7 | $20,882 | 2024 |
| Cochlear Americas | 3 | $15,667 | 2024 |
| Dompe US, Inc. | 1 | $15,000 | 2024 |
| MED-EL Corporation | 3 | $11,531 | 2024 |
| ABBVIE INC. | 1 | $8,000 | 2024 |
| 3NT Medical | 1 | $4,500 | 2024 |
| Heidelberg Engineering, Inc. | 1 | $3,000 | 2024 |
| Genentech, Inc. | 1 | $2,896 | 2024 |
| Carl Zeiss Meditec, Inc. | 2 | $2,500 | 2024 |
| Medical Device Business Services, Inc. | 1 | $1,500 | 2024 |
| Smith+Nephew, Inc. | 7 | $1,225 | 2024 |
| QIAGEN, LLC | 3 | $610 | 2024 |
| Teleflex LLC | 1 | $151 | 2024 |
| Grace Medical, Inc. | 1 | $123 | 2024 |
| Gyrus ACMI, Inc. | 4 | $65 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Royalty or License | 15 | $797,048 |
| Research payment | 26 | $519,035 |
| Grant | 8 | $307,250 |
| Education | 12 | $101,618 |
| Charitable Contribution | 2 | $59,947 |
| Long term medical supply or device loan | 9 | $7,176 |
| Space rental or facility fees (teaching hospital only) | 1 | $3,000 |
| Debt forgiveness | 3 | $610 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | KARL STORZ Endoscopy-America | $21,729 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | KARL STORZ Endoscopy-America | $19,319 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | KARL STORZ Endoscopy-America | $13,813 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | KARL STORZ Endoscopy-America | $12,625 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | KARL STORZ Endoscopy-America | $11,366 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | KARL STORZ Endoscopy-America | $8,859 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | KARL STORZ Endoscopy-America | $7,864 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | KARL STORZ Endoscopy-America | $623 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | KARL STORZ Endoscopy-America | $381 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | KARL STORZ Endoscopy-America | $351 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | KARL STORZ Endoscopy-America | $182 | Education | In-kind items and services | IMAGE 1 Device, VIDEOIMAGING | 2024 | |
| 2024-12-31 | Teleflex LLC | $151 | Long term medical supply or device loan | In-kind items and services | WECK Device, SURGICAL | 2024 | |
| 2024-11-27 | Cochlear Americas | $3,290 | Research payment | Cash or cash equivalent | Improving clinical efficiency with population mean mapping and modified follow-up schedule | 2024 | |
| 2024-11-14 | Bausch & Lomb Americas Inc. | $137,099 | Royalty or License | Cash or cash equivalent | VISUDYNE Drug, Ophthalmology | 2024 | |
| 2024-10-30 | Gyrus ACMI, Inc. | $13 | Royalty or License | Cash or cash equivalent | SMART Device, Ear, Nose, Throat | 2024 | |
| 2024-10-23 | Grace Medical, Inc. | $123 | Royalty or License (4 payments) | Cash or cash equivalent | OTOSHIELD PROTECTIVE BARRIER DRAPE Medical Supply, OTOLOGY | 2024 | |
| 2024-10-22 | Regeneron Pharmaceuticals, Inc. | $11,625 | Research payment | Cash or cash equivalent | EYLEA Biological, OPHTHALMOLOGY | Anti-VEGF therapy for Acute Thyroid Eye Disease (AcTED study) | 2024 |
| 2024-09-24 | Biogen, Inc. | $807 | Royalty or License | Cash or cash equivalent | 2024 | ||
| 2024-09-16 | QIAGEN, LLC | $80 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-09-09 | KYOWA KIRIN, INC. | $11,500 | Research payment | Cash or cash equivalent | Drug | A Phase 2, Multicenter, Randomized, Double-Masked, Parallel Group Study to Assess the Efficacy and Safety of KHK4951, a | 2024 |
| 2024-09-09 | KYOWA KIRIN, INC. | $5,000 | Research payment | Cash or cash equivalent | Drug | A Phase 2, Multicenter, Randomized, Double-Masked, Parallel Group Study to Assess the Efficacy and Safety of KHK4951, a | 2024 |
| 2024-09-09 | KYOWA KIRIN, INC. | $5,000 | Research payment | Cash or cash equivalent | Drug | A Phase 2, Multicenter, Randomized, Double-Masked, Parallel Group Study to Assess the Efficacy and Safety of KHK4951, a | 2024 |
| 2024-09-09 | KYOWA KIRIN, INC. | $1,500 | Research payment | Cash or cash equivalent | Drug | A Phase 2, Multicenter, Randomized, Double-Masked, Parallel Group Study to Assess the Efficacy and Safety of KHK4951, a | 2024 |
| 2024-09-09 | KYOWA KIRIN, INC. | $1,500 | Research payment | Cash or cash equivalent | Drug | A Phase 2, Multicenter, Randomized, Double-Masked, Parallel Group Study to Assess the Efficacy and Safety of KHK4951, a | 2024 |
| 2024-09-09 | KYOWA KIRIN, INC. | $200 | Research payment | Cash or cash equivalent | Drug | A Phase 2, Multicenter, Randomized, Double-Masked, Parallel Group Study to Assess the Efficacy and Safety of KHK4951, a | 2024 |
| 2024-08-26 | Regeneron Pharmaceuticals, Inc. | $235,250 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-08-23 | Medical Device Business Services, Inc. | $1,500 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-08-20 | Regeneron Pharmaceuticals, Inc. | $30,924 | Research payment | Cash or cash equivalent | EYLEA Biological, OPHTHALMOLOGY | Anti-VEGF therapy for Acute Thyroid Eye Disease (AcTED study) | 2024 |
| 2024-08-14 | Bausch & Lomb Americas Inc. | $219,047 | Royalty or License | Cash or cash equivalent | VISUDYNE Drug, Ophthalmology | 2024 | |
| 2024-08-14 | Gyrus ACMI, Inc. | $16 | Royalty or License | Cash or cash equivalent | SMART Device, Ear, Nose, Throat | 2024 | |
| 2024-08-08 | Regeneron Pharmaceuticals, Inc. | $1,000 | Research payment | Cash or cash equivalent | EYLEA Biological, OPHTHALMOLOGY | Anti-VEGF therapy for Acute Thyroid Eye Disease (AcTED study) | 2024 |
| 2024-08-02 | MED-EL Corporation | $5,800 | Long term medical supply or device loan | In-kind items and services | BCI 602 Kit Device, Bone Conduction Implant | 2024 | |
| 2024-07-31 | QIAGEN, LLC | $498 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-07-16 | Carl Zeiss Meditec, Inc. | $250 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-07-10 | Sumitomo Pharma Co., Ltd. | $44,947 | Charitable Contribution | Cash or cash equivalent | 2024 | ||
| 2024-07-01 | Smith+Nephew, Inc. | $175 | Long term medical supply or device loan | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2024 | |
| 2024-07-01 | Smith+Nephew, Inc. | $175 | Long term medical supply or device loan | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2024 | |
| 2024-07-01 | Smith+Nephew, Inc. | $175 | Long term medical supply or device loan | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2024 | |
| 2024-07-01 | Smith+Nephew, Inc. | $175 | Long term medical supply or device loan | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2024 | |
| 2024-07-01 | Smith+Nephew, Inc. | $175 | Long term medical supply or device loan | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2024 | |
| 2024-07-01 | Smith+Nephew, Inc. | $175 | Long term medical supply or device loan | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2024 | |
| 2024-07-01 | Smith+Nephew, Inc. | $175 | Long term medical supply or device loan | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2024 | |
| 2024-06-27 | QIAGEN, LLC | $31 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-06-04 | Gyrus ACMI, Inc. | $16 | Royalty or License | Cash or cash equivalent | SMART Device, Ear, Nose, Throat | 2024 | |
| 2024-05-24 | Biogen, Inc. | $890 | Royalty or License | Cash or cash equivalent | 2024 | ||
| 2024-05-23 | Amgen Inc. | $219,468 | Research payment | Cash or cash equivalent | Mapping Neuroprotective Receptor Proteins in the Human Cochlea | 2024 | |
| 2024-05-17 | Medtronic, Inc. | $50,000 | Grant | Cash or cash equivalent | STRAIGHTSHOT Device, High Speed Surgical Drills and Tools | 2024 | |
| 2024-05-17 | ABBVIE INC. | $8,000 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-05-15 | Bausch & Lomb Americas Inc. | $252,846 | Royalty or License | Cash or cash equivalent | VISUDYNE Drug, Ophthalmology | 2024 | |
| 2024-05-10 | Inspire Medical Systems, Inc. | $800 | Research payment | Cash or cash equivalent | INSPIRE Device, NEUROLOGY | PREDICTOR STUDY | 2024 |
| 2024-05-09 | Carl Zeiss Meditec, Inc. | $2,250 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-05-02 | Dompe US, Inc. | $15,000 | Charitable Contribution | Cash or cash equivalent | 2024 | ||
| 2024-04-26 | Inspire Medical Systems, Inc. | $1,700 | Research payment | Cash or cash equivalent | INSPIRE Device, NEUROLOGY | HOME STUDY | 2024 |
| 2024-04-23 | Biogen, Inc. | $73 | Royalty or License | Cash or cash equivalent | 2024 | ||
| 2024-04-16 | Regeneron Pharmaceuticals, Inc. | $5,000 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-04-16 | Regeneron Pharmaceuticals, Inc. | $5,000 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-04-10 | 3NT Medical | $4,500 | Education | Cash or cash equivalent | Colibri Micro ENT Scope Device, Otolaryngology | 2024 | |
| 2024-03-27 | Biogen, Inc. | $7,664 | Research payment | Cash or cash equivalent | A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Retinal Gene Therapy in Subjects with Choroideremia P | 2024 | |
| 2024-03-14 | Janssen Research & Development, LLC | $100,047 | Research payment | Cash or cash equivalent | MGT021 | 2024 | |
| 2024-03-14 | Janssen Research & Development, LLC | $14,813 | Research payment | Cash or cash equivalent | MGT021 | 2024 | |
| 2024-03-14 | Janssen Research & Development, LLC | $3,500 | Research payment | Cash or cash equivalent | MGT021 | 2024 | |
| 2024-03-08 | Biogen, Inc. | $7,955 | Royalty or License | Cash or cash equivalent | 2024 | ||
| 2024-03-08 | Biogen, Inc. | $2,863 | Royalty or License | Cash or cash equivalent | 2024 | ||
| 2024-03-08 | Biogen, Inc. | $627 | Royalty or License | Cash or cash equivalent | 2024 | ||
| 2024-02-27 | Heidelberg Engineering, Inc. | $3,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Spectralis Device, Ophthalmology Imaging Equipment | 2024 | |
| 2024-02-27 | Gyrus ACMI, Inc. | $19 | Royalty or License | Cash or cash equivalent | SMART Device, Ear, Nose, Throat | 2024 | |
| 2024-02-19 | Cochlear Americas | $9,086 | Research payment | In-kind items and services | Multicenter Study for Enhancing Auditory Brainstem Implant (ABI) | 2024 | |
| 2024-02-14 | Bausch & Lomb Americas Inc. | $174,647 | Royalty or License | Cash or cash equivalent | VISUDYNE Drug, Ophthalmology | 2024 | |
| 2024-02-06 | bioMerieux Inc | $36,045 | Research payment | Cash or cash equivalent | Chromid EPISEQ | 2024 | |
| 2024-02-02 | Inspire Medical Systems, Inc. | $8,057 | Research payment | Cash or cash equivalent | INSPIRE Device, NEUROLOGY | PREDICTOR STUDY | 2024 |
| 2024-02-02 | Inspire Medical Systems, Inc. | $3,145 | Research payment | Cash or cash equivalent | INSPIRE Device, NEUROLOGY | PREDICTOR STUDY | 2024 |
| 2024-01-29 | MED-EL Corporation | $5,198 | Research payment | Cash or cash equivalent | ADHEAR Professional Kit Device, Bone Conduction System | ADHEAR in infants with Down Syndrome and minimal hearing loss | 2024 |
| 2024-01-29 | MED-EL Corporation | $533 | Research payment | Cash or cash equivalent | ADHEAR Professional Kit Device, Bone Conduction System | ADHEAR in infants with Down Syndrome and minimal hearing loss | 2024 |
| 2024-01-21 | Cochlear Americas | $3,290 | Research payment | Cash or cash equivalent | Improving clinical efficiency with population mean mapping and modified follow-up schedule | 2024 | |
| 2024-01-19 | Inspire Medical Systems, Inc. | $31,250 | Research payment | Cash or cash equivalent | INSPIRE Device, NEUROLOGY | PEDIATRIC PAS STUDY | 2024 |
| 2024-01-16 | Genentech, Inc. | $2,896 | Research payment | Cash or cash equivalent | Phase 2 of RO7171009 in GA | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Boston, MA, county Suffolk County, MA, state Massachusetts; placed by its city name.
| Measure | Place (city or town) Boston, MA | County Suffolk County, MA | State Massachusetts |
|---|---|---|---|
| Population B01003 | 666,442 | 785,121 | 7,044,056 |
| Population, 2020 census P1 | 675,647 | 797,936 | 7,029,917 |
| Median age B01002 | 33.3 | 33.9 | 40.0 |
| Under 18 B01001 | 15.1% | 16.0% | 19.4% |
| 65 and over B01001 | 13.0% | 13.3% | 17.9% |
| Households B11001 | 283,374 | 327,167 | 2,785,042 |
| Foreign born B05002 | 27.8% | 29.8% | 18.0% |
| Median household income B19013 | $97,344 | $95,631 | $103,960 |
| Median family income B19113 | $116,436 | $112,072 | $131,675 |
| Per capita income B19301 | $61,698 | $58,636 | $57,897 |
| Poverty rate B17001 | 16.6% | 16.2% | 10.0% |
| Unemployment rate B23025 | 6.1% | 6.3% | 5.2% |
| Civilian labor force B23025 | 402,354 | 468,636 | 3,911,446 |
| Mean commute (minutes) B08013 | 30.3 | 30.9 | 29.1 |
| Bachelor's degree or higher B15003 | 54.9% | 50.6% | 47.3% |
| Housing units B25001 | 310,625 | 357,290 | 3,030,406 |
| Owner-occupied B25003 | 35.7% | 36.5% | 62.5% |
| Renters B25003 | 64.3% | 63.5% | 37.5% |
| Median home value B25077 | $731,700 | $705,800 | $562,100 |
| Median gross rent B25064 | $2,147 | $2,129 | $1,762 |
| White, not Hispanic B03002 | 44.1% | 43.6% | 66.6% |
| Black B03002 | 19.3% | 17.1% | 6.4% |
| Hispanic or Latino B03002 | 19.3% | 23.2% | 13.3% |
| Asian B03002 | 10.3% | 9.2% | 7.3% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Economy now FRED unemployment 4.3% in Sep 2026 (4.6% a year earlier); per capita personal income $98,700 in 2025, up 27% in five years (+2.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Boston, MA.
Comments